Design of respirable sprayed microparticles of encapsulated bacteriophages
Antibiotic resistance is exponentially increasing, and the number of deaths caused by bacterial infections is expected to surge. When dealing with the respiratory system, inefficient antibiotics heighten the chance of death from bacterial infection. However, the alternatives to antibiotics are limit...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_8e8a69e653804d8888afdea4aec50b12 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Alberto Baldelli |e author |
700 | 1 | 0 | |a Mingtao Liang |e author |
245 | 0 | 0 | |a Design of respirable sprayed microparticles of encapsulated bacteriophages |
260 | |b Frontiers Media S.A., |c 2023-06-01T00:00:00Z. | ||
500 | |a 2674-0850 | ||
500 | |a 10.3389/fddev.2023.1209534 | ||
520 | |a Antibiotic resistance is exponentially increasing, and the number of deaths caused by bacterial infections is expected to surge. When dealing with the respiratory system, inefficient antibiotics heighten the chance of death from bacterial infection. However, the alternatives to antibiotics are limited. Bacteriophages are a valid option since they can target a specific type of bacterium. Bacteriophages are highly specific and can avoid any side effects when delivered. However, their poor stability makes their use inefficient. Encapsulation is commonly used to protect any bioactive compound for different types of delivery. In the case of respiratory delivery, particle engineering is used to generate stable dry powders to target the nasal or lung areas. This review article provides a guideline for engineering a process of nasal dry powders of encapsulated bacteriophages. | ||
546 | |a EN | ||
690 | |a particle engineering | ||
690 | |a respiratory delivery | ||
690 | |a spraying techniques | ||
690 | |a phage therapy | ||
690 | |a bacteriophage | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Drug Delivery, Vol 3 (2023) | |
787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fddev.2023.1209534/full | |
787 | 0 | |n https://doaj.org/toc/2674-0850 | |
856 | 4 | 1 | |u https://doaj.org/article/8e8a69e653804d8888afdea4aec50b12 |z Connect to this object online. |